Here we have evaluated cross-sectional associations of adiponectin and albuminuria at baseline in the DPP cohort, and tested the hypothesis that treatment-related increases in adiponectin may reduce albuminuria in obesity. This evidence concerns the gene ADIPOQ and Obesity.